Encarna Cruz

Encarna Cruz is the director general of the Spanish Association of Biosimilar Medicines (BioSim). She is actively involved in advocating for the development of biosimilars in Spain, highlighting the challenges and delays in bringing these alternatives to market, particularly in the context of expiring patents for original high-cost medications like Keytruda.